Health Condition 1: O720- Third-stage hemorrhage
Conditions
Interventions
Intervention1: Carbetocin: The study medication carbetocin 100 mcg will be diluted with 8 ml of normal saline and will be administered intravenously slowly over 2 -3 minutes after the birth of the b
Sponsors
Rajendra Institute of Medical Sciences Ranchi
Eligibility
Inclusion criteria
Inclusion criteria: 1.women with singleton pregnancy undergoing elective or emergency cesarean section with greater than or equal to 37 weeks of gestation . 2. Not hypersensitive to oxytocin or carbetocin
Exclusion criteria
Exclusion criteria: 1.women with multiple gestation ,morbidly adherent placenta 2. women undergoing cesarean section with general anaesthesia 3.thromboembolic disorder , coagulation defect
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out the effectiveness of caebetocin versus oxytocin in prevention of postpartum haemorrhage in patients undergoing cesarean sectionTimepoint: Patient undergoing cesarean sections will be monitored for postpartum haemorrhage till 24 hours after the birth of baby . | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To asses the need for other uterotonics drugs 2.To assess the need for blood transfusion in post partum haemorrhage. Timepoint: during cesarean section and within 24 hours of delivery. | — |
Countries
India
Contacts
Public ContactDr shiwani kumari
Rajendra institute of medical sciences ranchi
Outcome results
None listed